Regulation of neural and peripheral cytokine production by benzodiazepines and endogenous anxiogenic peptides.
Taupin
V
V
INSERM U25, Hôpital Necker, Paris, France.
Toulmond
S
S
Benavides
J
J
Gogusev
J
J
Descamps-Latscha
B
B
Zavala
F
F
D000818:Animals; D001570:Benzodiazepinones / Q000494:pharmacology*; D001930:Brain Injuries / Q000503:physiopathology*; D002352:Carrier Proteins / Q000502:physiology*; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D016207:Cytokines / Q000096:biosynthesis* / Q000235:genetics; D026261:Diazepam Binding Inhibitor; D005786:Gene Expression Regulation / Q000187:drug effects*; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007249:Inflammation; D008070:Lipopolysaccharides / Q000494:pharmacology; D009000:Monocytes / Q000187:drug effects* / Q000378:metabolism; D009457:Neuroglia / Q000187:drug effects* / Q000378:metabolism; D015213:Neuroimmunomodulation / Q000502:physiology*; D009479:Neuropeptides / Q000494:pharmacology*; D010446:Peptide Fragments / Q000494:pharmacology*; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D011963:Receptors, GABA-A / Q000187:drug effects / Q000502:physiology*
D001570:Benzodiazepinones; D002352:Carrier Proteins; D016207:Cytokines; D026261:Diazepam Binding Inhibitor; D008070:Lipopolysaccharides; D009479:Neuropeptides; D010446:Peptide Fragments; D012333:RNA, Messenger; D011963:Receptors, GABA-A; C060941:triakontatetraneuropeptide; C028513:4'-chlorodiazepam